Mosunetuzumab Safety Profile in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience from a Pivotal Phase I/II Trial
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2024）
关键词
Adverse events,Bispecific antibody,Cytokine release syndrome,Follicular lymphoma,Lymphoid malignancies
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要